BPC-157 vs TB-500 (2026): Dosage, Human Trials & FDA Compounding Status

BPC-157 remains the most-searched research peptide in North America. Here's how it compares to TB-500 -- mechanisms, dosage protocols from research literature, what human trials actually show, and where the FDA's compounding review and WADA's ban status stand as of September 2026.